Mirus Bio is a biotechnology company based in the United States, founded in 1995. The company is known for its slogan "The Transfection Experts" and its mission to Deliver Innovation, Empower Discovery, and Improve Life.
For over 25 years, Mirus Bio has been at the forefront of developing transfection reagents and proprietary technologies for nucleic acid delivery applications. The company's work is characterized by its technical prowess and cutting-edge approach, fostering a culture of creativity, responsibility, and respect among its team members.
Mirus Bio operates with the aim of supporting its customers and partners to achieve strong results. The company, in collaboration with Gamma Biosciences, is contributing to the future of science and medicine by developing products that enable product developers within the cell and gene therapy space.
As the world enters a new era in addressing and conquering life-altering diseases, Mirus Bio is committed to expanding its expertise and leadership in transfection to play an integral role in the future of advanced therapies. The company prides itself on being a part of Gamma Biosciences Company.
There is no investment information
No recent news or press coverage available for Mirus Bio.